dual gip glp 1 receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Targeting GLP-1, GIP & GCG

2026 is the year in which the long-term themes, the true drivers of sustainable success for the burgeoning landscape of obesity treatment, prescription medicines and beyond, become apparent

No injections

however, this contradicts established trial data favoring SGLT2 inhibitors for heart failure and should be interpreted cautiously due to possible residual confounding

Its designed to complement the benefits of GLP-1 medications while reducing the discomfort they can cause

These one-page guides will answer your patient's most common questions when starting a GLP-1 RA or SGLT2i medication..

Some people report minor weight loss during their first week, but you shouldnt go into this process expecting those kinds of results its more common to start losing weight a few weeks into it and then up to two pounds each week (depending on your diet and exercise habits).And although side effects can occur when taking GLP1 drops , their frequency and severity are usually low